Laddar populära aktier...
Redeye takes a positive stance towards the partial divestment of Aspire.
Redeye provides a brief comment on Freemelt's order from a global orthopedic implant OEM, marking a ...
Redeye lowers its forecasts for Q3 and 2024 somewhat on the back of a slightly softer outlook in Nor...
Redeye offers a preview of Doro's Q3 results set to be released on October 25.
Minor estimate changes Gross margin improvements set to continue Trading at NTM EV/EBITA of ~10x Wh...
We trim '24e-'26e ARR by 1% on continued macro weakness Still awaiting a return in B2C business mome...
Solid Q3e with 7% organic growth and 22% EBITDA growth US market could be sluggish again, but focus ...
Efterfrågan har överlag hittills varit stabil, men med en svagare efterfrågan inom de breda industri...
Redeye has a positive view on the news from this morning, announcing that Saniona's collaboration wi...
Redeye comments on Truecaller ahead of its Q3 results, which are due on 7 November.
Q3e: -1% organic sales growth y-o-y, 7% adj. EBITA margin We decrease '25e-'26e sales by 2% Trading ...
Redeye shares its preview of BONESUPPORT’s Q3 2024 results, due October 24.
Redeye gives its preview on OssDsign’s Q3 2024 report, due on November 5.
Redeye offers a preview of SSH's Q3 results set to be released on October 24.
MoveByBike Europe AB ("MoveByBike" eller ”Bolaget”) meddelade den 10 oktober 2024 att Airmee blir en...